Enhancer elements regulate the tissue- and developmental-stage-specific expression of genes. Recent estimates suggest that there are more than 50,000 enhancers in mammalian cells. At least a subset of enhancers has been shown to recruit RNA polymerase II transcription complexes and to generate enhancer transcripts. Here, we provide an overview of enhancer function and discuss how transcription of enhancers or enhancer-generated transcripts could contribute to the regulation of gene expression during development and differentiation.
References
[1]
Orphanides, G.; Reinberg, D. A unified theory of gene expression. Cell 2002, 108, 439–451, doi:10.1016/S0092-8674(02)00655-4.
[2]
Bernstein, B.E.; Birney, E.; Dunham, I.; Green, E.D.; Gunter, C.; Snyder, M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57–74.
[3]
Juven-Gershon, T.; Kadonaga, J.T. Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev. Biol. 2010, 339, 225–229, doi:10.1016/j.ydbio.2009.08.009.
[4]
Ghirlando, R.; Giles, K.; Gowher, H.; Xiao, T.; Xu, Z.; Yao, H.; Felsenfeld, G. Chomatin domains, insulators, and the regulation of gene expression. Biochim. Biophys. Acta 2012, 1819, 644–651, doi:10.1016/j.bbagrm.2012.01.016.
[5]
Bulger, M.; Groudine, M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011, 144, 327–339, doi:10.1016/j.cell.2011.01.024.
[6]
Shen, Y.; Yue, F.; McCleary, D.F.; Ye, Z.; Edsall, L.; Kuan, S.; Wagner, U.; Dixon, J.; Lee, L.; Lobanenkov, V.V.; Ren, B. A map of the cis-regulatory sequences in the mouse genome. Nature 2012, 488, 116–120.
[7]
Banerji, J.; Rusconi, S.; Schaffner, W. Expression of a beta-globin gene is enhanced by remote SV40 sequences. Cell 1981, 27, 299–308, doi:10.1016/0092-8674(81)90413-X.
[8]
Müller, M.M.; Gerster, T.; Schaffner, W. Enhancer sequences and the regulation of gene transcription. Eur. J. Biochem. 1988, 176, 485–495, doi:10.1111/j.1432-1033.1988.tb14306.x.
[9]
Wu, C. The 5’ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I. Nature 1980, 286, 854–860, doi:10.1038/286854a0.
[10]
Collis, P.; Antoniou, M.; Grosveld, F. Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J. 1990, 9, 233–240.
[11]
Ellis, J.; Tan-Un, K.C.; Harper, A.; Michalovich, D.; Yannoutsos, N.; Philipsen, S.; Grosveld, F. A dominant chromatin-opening activity in 5'hypersensitive site 3 of the human beta-globin locus control region. EMBO J. 1996, 15, 562–568.
[12]
Valen, E.; Sandelin, A. Genomic and chromatin signals underlying transcription start-site selection. Trends Genet. 2011, 27, 475–485, doi:10.1016/j.tig.2011.08.001.
[13]
Li, Q.; Peterson, K.R.; Fang, X. Stamatoyannopoulos G. Locus control regions. Blood 2002, 100, 3077–3086, doi:10.1182/blood-2002-04-1104.
[14]
Bulger, M.; Groudine, M. Looping versus linking: toward a model for long-distance gene activation. Genes Dev. 1999, 13, 2465–2477, doi:10.1101/gad.13.19.2465.
[15]
Engel, J.D.; Tanimoto, K. Looping, linking, and chromatin activity: new insights into beta-globin locus regulation. Cell 2000, 100, 499–502, doi:10.1016/S0092-8674(00)80686-8.
[16]
Fleetwood, M.R.; Ho, Y.; Cooke, N.E.; Liebhaber, S.A. DNase I hypersensitive site II of the human growth hormone locus control region mediates an essential and distinct long-range enhancer function. J. Biol. Chem. 2012, 287, 25454–25465.
[17]
Tanimoto, K.; Liu, Q.; Bungert, J.; Engel, J.D. Effects of altered gene order or orientation of the locus control region on human beta-globin gene expression in mice. Nature 1999, 398, 344–348.
[18]
Heintzman, N.D.; Hon, G.C.; Hawkins, R.D.; Kheradpour, P.; Stark, A.; Harp, L.F.; Ye, Z.; Lee, L.K.; Stuart, R.K.; Ching, C.W.; et al. Histone modifications at human enhancers reflect global cell type-specific gene expression. Nature 2009, 459, 108–112.
[19]
Ernst, J.; Kheradpour, P.; Mikkelsen, T.S.; Shoresh, N.; Ward, L.D.; Epstein, C.B.; Zhang, X.; Wang, L.; Issner, R.; Coyne, M.; Ku, M.; et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473, 43–49.
[20]
Zentner, G.E.; Scacheri, P.C. The chromatin fingerprint of gene enhancer elements. J. Biol. Chem. 2012, 287, 30888–30896, doi:10.1074/jbc.R111.296491.
[21]
Xi, H.; Shulha, H.P.; Lin, J.M.; Vales, T.R.; Fu, Y.; Bodine, D.; McKay, R.D.; Chenoweth, J.G.; Tesar, P.J.; Furey, T.S.; et al. Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome. PLoS Genet. 2007, 3, doi:10.1371/journal.pgen.0030136.
[22]
Koch, F.; Fenouil, R.; Gut, M.; Cauchy, P.; Albert, T.K.; Zacarias-Cabeza, J.; Spicuglia, S.; de la Chapelle, A.L.; Heidemann, M.; Hintermair, C.; et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat. Struct. Mol. Biol. 2011, 18, 956–963.
[23]
Creyghton, M.P.; Cheng, A.W.; Welstead, G.G.; Kooistra, T.; Carey, B.W.; Steine, E.J.; Hanna, J.; Lodato, M.A.; Frampton, G.M.; Sharp, P.A.; et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 2010, 107, 21931–21936.
Zhou, Z.; Li, X.; Deng, C.; Ney, P.A.; Huang, S.; Bungert, J. USF and NF-E2 cooperate to regulate the recruitment and activity of RNA polymerase II in the beta-globin gene locus. J. Biol. Chem. 2010, 285, 15894–15905.
[26]
Wang, J.; Zhuang, J.L.; Iyer, S.; Lin, X.Y.; Whitfield, T.W.; Greven, M.C.; Pierce, B.G.; Dong, X.J.; Kundaje, A.; Cheng, Y.; et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. 2012, 22, 1798–1812.
[27]
Neph, S.; Vierstra, J.; Stergachis, A.B.; Reynolds, A.P.; Haugen, E.; Vernot, B.; Thurman, R.E.; John, S.; Sandstrom, R.; Johnson, A.K.; et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012, 489, 83–90.
[28]
Johnson, K.D.; Grass, J.A.; Park, C.; Im, H.; Choi, K.; Bresnick, E.H. Highly restricted localization of RNA polymerase II within a locus control region of a tissue-specific chromatin domain. Mol. Cell Biol. 2003, 23, 6484–6493, doi:10.1128/MCB.23.18.6484-6493.2003.
[29]
Vieira, K.F.; Levings, P.P.; Hill, M.A.; Crusselle, V.J.; Kang, S.H.; Engel, J.D.; Bungert, J. Recruitment of transcription complexes to the beta-globin gene locus control region in vivo and in vitro. J. Biol. Chem. 2004, 279, 50350–50357.
[30]
Kim, T.K.; Hemberg, M.; Gray, J.M.; Costa, A.M.; Bear, D.M.; Wu, J.; Harmin, D.A.; Laptewicz, M.; Barbara-Haley, K.; Kuersten, S.; et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465, 182–187.
[31]
de Santa, F.; Barozzi, I.; Mietton, F.; Ghisletti, S.; Polletti, S.; Tusi, B.K.; Muller, H.; Ragoussis, J.; Wei, C.L.; Natoli, G. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010, 8, doi:10.1371/journal.pbio.1000384.
[32]
Djebali, S.; Davis, C.A.; Merkel, A.; Dobin, A.; Lassmann, T.; Mortazavi, A.; Tanzer, A.; Lagarde, J.; Lin, W.; Schlesinger, F.; et al. Landscape of transcription in human cells. Nature 2012, 489, 101–108.
[33]
Jimenez, G.; Griffiths, S.D.; Ford, A.M.; Greaves, M.F.; Enver, T. Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl. Acad. Sci. USA 1992, 89, 10618–10622.
[34]
Buratowski, S.; Hahn, S.; Guarente, L.; Sharp, P.A. Five intermediate complexes in transcription initiation by RNA polymerase II. Cell 1989, 56, 549–561, doi:10.1016/0092-8674(89)90578-3.
[35]
Roeder, R.G. The role of general transcription factors in transcription by RNA polymerase II. Trends Biochem. Sci. 1996, 21, 327–335.
[36]
Kim, T.H.; Barrera, L.O.; Zheng, M.; Qu, C.; Singer, M.A.; Richmond, T.A.; Wu, Y.; Green, R.D.; Ren, B. A high-resolution map of active promoters in the human genome. Nature 2005, 436, 876–880.
[37]
Gershenzon, N.I.; Ioshikhes, I.P. Synergy of human Pol II core promoter elements revealed by statistical sequence analysis. Bioinformatics 2005, 21, 1295–1300, doi:10.1093/bioinformatics/bti172.
[38]
Karlic, R.; Chung, H.R.; Lassere, J.; Vlahovicek, K.; Vingron, M. Histone modification levels are predictive for gene expression. Proc. Natl. Acad. Sci. USA 2010, 107, 2926–2931.
[39]
Iborra, F.J.; Pombo, A.; McManus, J.; Jackson, D.A.; Cook, P.R. The topology of transcription by immobilized polymerases. Exp. Cell Res. 1996, 229, 167–173, doi:10.1006/excr.1996.0355.
[40]
Deng, B.; Melnik, S.; Cook, P.R. Transcription factories, chromatin loops, and the dysregulation of gene expression in malignancy. Semin. Cancer Biol. 2012. in press.
[41]
Edelman, L.B.; Fraser, P. Transcription factories: Genetic programming in three dimensions. Curr. Opin. Genet. Dev. 2012, 22, 110–114, doi:10.1016/j.gde.2012.01.010.
[42]
Schoenfelder, S.; Sexton, T.; Chakalova, L.; Cope, N.F.; Horton, A.; Andrews, S.; Kurukuti, S.; Mitchell, J.A.; Umlauf, D.; Dimitrova, D.S.; et al. Preferential association between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat. Genet. 2010, 42, 53–61.
[43]
Lanctot, C.; Cheutin, T.; Cremer, M.; Cavalli, G.; Cremer, T. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat. Rev. Genet. 2007, 8, 104–115, doi:10.1038/nrg2041.
[44]
Niedojadlo, J.; Perret-Vivancos, C.; Kalland, K.H.; Cmarko, D.; Cremer, T.; van Driel, R.; Fakan, S. Transcribed DNA is preferentially located in the perichromatin region of mammalian nuclei. Exp. Cell Res. 2011, 317, 433–444, doi:10.1016/j.yexcr.2010.10.026.
[45]
Fromm, G.; Cadiz-Rivera, B.; de Vries, C.; Getman, M.; McGrath, K.E.; Kingsley, P.D.; Fields, J.; Fiering, S.; Bulger, M. An embryonic stage-specific enhancer within the murine beta-globin locus mediates domain-wide histone hyperacetylation. Blood 2011, 117, 5207–5214, doi:10.1182/blood-2010-08-302018.
[46]
Vernimmen, D.; Lynch, M.D.; DeGobbi, M.; Garrick, D.; Sharpe, J.A.; Sloane-Stanley, J.A.; Smith, A.J.H.; Higgs, D.R. Polycomb eviction as a new distant enhancer function. Genes Dev. 2011, 25, 1583–1588.
[47]
Morey, L.; Helin, K. Polycomb group protein-mediated repression of transcription. Trends Biochem. Sci. 2010, 35, 323–332, doi:10.1016/j.tibs.2010.02.009.
Rodriguez-Jato, S.; Nicholls, R.D.; Driscoll, D.J.; Yang, T.P. Characterization of cis- and trans-acting elements in the imprinted human SNURF-SNRPN locus. Nucl. Acids. Res. 2005, 33, 4740–4753.
[50]
Zhao, H.; Friedman, R.D.; Fournier, R.E.K. The locus control region activates serpin gene expression through recruitment of liver-specific transcription factors and RNA polymerase II. Mol. Cell Biol. 2007, 27, 5286–5295, doi:10.1128/MCB.00176-07.
[51]
Levings, P.P.; Bungert, J. The human beta-globin locus control region. Eur. J. Biochem. 2002, 269, 1589–1599, doi:10.1046/j.1432-1327.2002.02797.x.
[52]
Ragoczy, T.; Bender, M.A.; Telling, A.; Byron, R.; Groudine, M. The locus control region is required for association of the murine beta-globin locus with engaged transcription factories during erythroid maturation. Genes Dev. 2006, 20, 1447–1457, doi:10.1101/gad.1419506.
[53]
Francastel, C.; Walters, M.C.; Groudine, M.; Martin, D.I. A functional enhancer suppresses silencing of a transgene and prevents its localization close to centromeric heterochromatin. Cell 1999, 99, 259–269, doi:10.1016/S0092-8674(00)81657-8.
[54]
Sawado, T.; Halow, J.; Bender, M.A.; Groudine, M. The beta-globin locus control region (LCR) functions primarily by enhancing the transition from transcription initiation to elongation. Genes Dev. 2003, 17, 1009–1018, doi:10.1101/gad.1072303.
[55]
Song, S.H.; Kim, A.; Ragoczy, T.; Bender, M.A.; Groudine, M.; Dean, A. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation. Blood 2010, 116, 2356–2364, doi:10.1182/blood-2010-03-272252.
[56]
Nechaev, S.; Adelman, K. Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation. Biochim. Biophys. Acta. 2011, 1809, 34–45, doi:10.1016/j.bbagrm.2010.11.001.
[57]
Marks, H.; Kalkan, T.; Denissov, S.; Jones, K.; Hofemeister, H.; Nichols, J.; Stewart, A.F.; Smith, A.; Stunnenberg, H.G. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 2012, 149, 590–604, doi:10.1016/j.cell.2012.03.026.
[58]
Li, G.; Ruan, X.; Auerbach, R.K.; Sandhu, K.S.; Zheng, M.; Wang, P.; Poh, H.M.; Goh, Y.; Lim, J.; Zhang, J.; et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012, 148, 84–98, doi:10.1016/j.cell.2011.12.014.
[59]
Ong, C.T.; Corces, V.G. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 2011, 12, 283–293.
[60]
Tuan, D.; Kong, S.; Hu, K. Transcription of the hypersensitive site HS2 enhancer in erythroid cells. Proc. Natl. Acad. Sci. USA 1992, 89, 11219–11223, doi:10.1073/pnas.89.23.11219.
[61]
Zhu, X.; Ling, J.; Zhang, L.; Pi, W.; Wu, M.; Tuan, D. A facilitated tracking and transcription mechanism of long-range enhancer function. Nucleic Acids Res. 2007, 35, 5532–5544, doi:10.1093/nar/gkm595.
[62]
Leach, K.M.; Nightingale, K.; Igarashi, K.; Levings, P.P.; Engel, J.D.; Becker, P.P.; Bungert, J. Reconstitution of human beta-globin locus control region hypersensitive sites in the absence of chromatin assembly. Mol. Cell Biol. 2001, 21, 2629–2640, doi:10.1128/MCB.21.8.2629-2640.2001.
[63]
Routledge, S.J.; Proudfoot, N.J. Definition of transcriptional promoters in the human beta globin locus control region. J. Mol. Biol. 2002, 323, 601–611, doi:10.1016/S0022-2836(02)01011-2.
[64]
Schmitt, S.; Prestel, M.; Paro, R. Intergenic transcription through a polycomb group response element counteracts silencing. Genes Dev. 2005, 19, 697–708, doi:10.1101/gad.326205.
[65]
Walia, H.; Chen, H.Y.; Sun, J.M.; Holth, L.T.; Davie, J.R. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. J. Biol. Chem. 1998, 273, 14516–14522.
[66]
Hatzis, P.; Talianidis, I. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell 2002, 10, 1467–1477, doi:10.1016/S1097-2765(02)00786-4.
[67]
Rogers, R.J.; Chesrown, S.E.; Kuo, S.; Monnier, J.M.; Nick, H.S. Cytokine-inducible enhancer with promoter activity in both the rat and human manganese-superoxide dismutase genes. Biochem. J. 2000, 347, 233–242, doi:10.1042/0264-6021:3470233.
[68]
Kowalczyk, M.S.; Hughes, J.R.; Garrick, D.; Lynch, M.D.; Sharpe, J.A.; Sloane-Stanley, J.A.; McGowan, S.J.; de Gobbi, M.; Hosseini, M.; Vernimmen, D.; et al. Intragenic enhancers act as alternative promoters. Cell 2012, 45, 447–458.
[69]
Wang, D.; Garcia-Bassets, I.; Benner, C.; Li, W.; Sue, X.; Zhou, Y.; Qiu, J.; Lie, W.; Kaikkonen, M.U.; Ohgi, K.A.; et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474, 390–394.
[70]
Sanyal, A.; Lajoie, B.R.; Jain, G.; Dekker, J. The long-range interaction landscape of gene promoters. Nature 2012, 489, 109–113.
[71]
Khalil, A.; Guttman, M.; Huarte, M.; Garber, M.; Raj, A.; Rivea-Morales, D.; Thomas, K.; Presser, A.; Bernstein, B.E.; van Oudenaarden, A.; et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. USA 2009, 106, 11667–11672.
[72]
Orum, U.A.; Derrien, T.; Beringer, M.; Gumireddy, K.; Gardini, A.; Bussotti, G.; Lai, F.; Zytnicki, M.; Notredame, C.; Huang, Q.; et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143, 46–58, doi:10.1016/j.cell.2010.09.001.
[73]
Flynn, R.A.; Chang, H.Y. Active chromatin and noncoding RNAs: An intimate relationship. Curr. Opin. Genet. Dev. 2012, 22, 172–178, doi:10.1016/j.gde.2011.11.002.
[74]
Caudron-Herger, M.; Rippe, K. Nuclear architecture by RNA. Curr. Opin. Genet. Dev. 2012, 22, 179–187, doi:10.1016/j.gde.2011.12.005.
[75]
Shevtsov, S.P.; Dundr, M. Nucleation of nuclear bodies by RNA. Nat. Cell Biol. 2011, 13, 167–173, doi:10.1038/ncb2157.
[76]
Fnu, S.; Williamson, E.A.; de Haro, L.P.; Brenneman, M.; Wray, J.; Shaheen, M.; Radhakrishnan, K.; Lee, S.H.; Nickoloff, J.A.; Hromas, R. Methylation of histone H3 lysine 36 enhances DNA repair by non-homologous end-joining. Proc. Natl. Acad. Sci. USA 2011, 108, 540–545.
[77]
Rada-Iglesias, A.; Bajpai, R.; Swigut, T.; Brugmann, S.A.; Flynn, R.A.; Wysocka, J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470, 279–283.
[78]
Magnani, L.; Eeckhoute, J.; Lupien, M. Pioneer factors: directing transcriptional regulators within the chromatin environment. Trends Genet. 2011, 27, 465–474, doi:10.1016/j.tig.2011.07.002.
[79]
Zhu, Y.; van Essen, D.; Saccani, S. Cell type-specific control of enhancer activity by H3K9 trimethylation. Mol. Cell 2012, 46, 408–423, doi:10.1016/j.molcel.2012.05.011.
[80]
Chong, M.M.; Simpson, N.; Ciofani, M.; Chen, G.; Collins, A.; Littman, D.R. Epigenetic propagation of CD4 expression is established by the Cd4 proximal enhancer in helper T-cells. Genes Dev. 2010, 24, 659–669, doi:10.1101/gad.1901610.
[81]
DuBose, A.J.; Smith, E.Y.; Johnstone, K.A.; Resnick, J.L. Temporal and developmental requirements for the Prader-Willi imprinting center. Proc. Natl. Acad. Sci. USA 2012, 109, 3446–3450.
[82]
Klein, S.; Gerster, T.; Picard, D.; Radbruch, A.; Schaffner, W. Evidence for transient requirement of the IgH enhancer. Nucl. Acids Res. 1985, 13, 8901–8912, doi:10.1093/nar/13.24.8901.
[83]
Yoo, E.J.; Cooke, N.E.; Liebhaber, S.A. An RNA-independent linkage of noncoding transcription to long-range enhancer function. Mol. Cell Biol. 2012, 32, 2020–2029, doi:10.1128/MCB.06650-11.
[84]
Sequeira-Mendes, J.; Gomez, M. On the opportunistic nature of transcription and replication initiation of the metazoan genome. Bioessays. 2011, 34, 119–125, doi:10.1002/bies.201100126.
[85]
Thanos, D.; Maniatis, T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 1995, 83, 1091–1100, doi:10.1016/0092-8674(95)90136-1.
